Interleukin-35: Expanding Its Job Profile

Journal of Interferon and Cytokine Research

Volumn 35, Issue 7, 2015, Pages 499-512

  Sawant, Deepali V ^a   Hamilton, Kristia ^a   Vignali, Dario A A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD8 ANTIGEN; HETERODIMER; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 35; PROTEIN P35; TRANSFORMING GROWTH FACTOR BETA; INTERLEUKIN DERIVATIVE;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CANCER MODEL; CHRONIC INFLAMMATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TROPHOBLAST; ANIMAL; IMMUNITY; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; HUMANS; IMMUNITY; IMMUNOMODULATION; INTERLEUKINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84937000772     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2015.0015     Document Type: Review

References (111)

1. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278(3):1910-1914.
2. Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK. 2008. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 38(12):3282-3289.
3. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12): 1380-1389.
4. Banchereau J, Pascual V, OGarra A. 2012. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 13(10):925-931.
5. Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L- Hermine A, Devergne O. 2008. Human CD4+ CD25 + Foxp3 + regulatory T cells do not constitutively express IL-35. J Immunol 181(10):6898-6905.
6. Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, Lawrie S, Fan B, OConnor RA, Anderton SM, Bar-Or A, Fillatreau S, Gray D. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209(5):1001-1010.
7. Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N. 2008. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol 180(5):2752-2756.
8. Belkaid Y, Chen W. 2010. Regulatory ripples. Nat Immunol 11(12):1077-1078.
9. Bettini M, Castellaw AH, Lennon GP, Burton AR, Vignali DA. 2012. Prevention of autoimmune diabetes by ectopic pancreatic beta-cell expression of interleukin-35. Diabetes 61(6): 1519-1526.
10. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. 2010. CD19( + )CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32(1):129-140.
11. Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC, Moore JS. 1995. Reduced surface expression of transforming growth factor beta receptor type II in mitogenactivated T cells from Sezary patients. Proc Natl Acad Sci U S A 92(12):5501-5505.
12. Chen C, Deng Y, Chen H, Wu X, Cheng S, Xu Y, Xiong W, Xie J. 2014. Decreased concentration of IL-35 in plasma of patients with asthma and COPD. Asian Pac J Allergy Immunol 32(3):211-217.
13. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. 2003. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25 + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198(12):1875-1886.
14. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093-1101.
15. Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DA. 2012. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 13(3):290-299.
16. Collison LW, Pillai MR, Chaturvedi V, Vignali DA. 2009. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 182(10):6121-6128.
17. Collison LW, Vignali DA. 2008. Interleukin-35: odd one out or part of the family? Immunol Rev 226:248-262.
18. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566-569.
19. Devergne O, Birkenbach M, Kieff E. 1997. Epstein-Barr virusinduced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A 94(22):12041-12046.
20. Devergne O, Coulomb-LHermine A, Capel F, Moussa M, Capron F. 2001. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 159(5):1763-1776.
21. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, Birkenbach M. 1996. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 70(2):1143-1153.
22. Dinarello CA. 2007. Historical insights into cytokines. Eur J Immunol 37 (Suppl 1):S34-S45.
23. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM. 2011. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 121(9):3645-3656.
24. Diveu C, McGeachy MJ, Boniface K, Stumhofer JS, Sathe M, Joyce-Shaikh B, Chen Y, Tato CM, McClanahan TK, de Waal Malefyt R, Hunter CA, Cua DJ, Kastelein RA. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182(9):5748-5756.
25. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, Mauri C. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178(12):7868-7878.
26. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. 2002. B cells regulate autoimmunity by provision of IL- 10. Nat Immunol 3(10):944-950.
27. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8(12):1372-1379.
28. Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, Mauri C. 2013. CD19 + CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 5(173):173ra23.
29. Garbers C, Hermanns HM, Schaper F, Muller-Newen G, Grotzinger J, Rose-John S, Scheller J. 2012. Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev 23(3):85-97.
30. Gershon RK, Kondo K. 1971. Infectious immunological tolerance. Immunology 21(6):903-914.
31. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hatscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361(21):2033-2045.
32. Glocker EO, Kotlarz D, Klein C, Shah N, Grimbacher B. 2011. IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci 1246:102-107.
33. Gravano DM, Vignali DA. 2012. The battle against immunopathology: infectious tolerance mediated by regulatory T cells. Cell Mol Life Sci 69(12):1997-2008.
34. Grohmann U, Belladonna ML, Bianchi R, Orabona C, Ayroldi E, Fioretti MC, Puccetti P. 1998. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity 9(3):315-323.
35. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27(5):786-800.
36. Hu Y, Dong C, Yue Y, Xiong S. 2014. In vivo delivery of interleukin-35 relieves coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells. Arch Virol 159(9):2411-2419.
37. Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, Chua KY. 2011. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 187(1): 462-471.
38. Huang Y, Lin YZ, Shi Y, Ji QW. 2013. IL-35: a potential target for the treatment of atherosclerosis. Pharmazie 68(10):793-795.
39. Hunter CA. 2005. New IL-12-family members: IL-23 and IL- 27, cytokines with divergent functions. Nat Rev Immunol 5(7):521-531.
40. Jafarzadeh A, Jamali M, Mahdavi R, Ebrahimi HA, Hajghani H, Khosravimashizi A, Nemati M, Najafipour H, Sheikhi A, Mohammadi MM, Daneshvar H. 2015. Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program. J Mol Neurosci 55(4):891-897.
41. Jin P, Ren H, Sun W, Xin W, Zhang H, Hao J. 2014. Circulating IL-35 in pancreatic ductal adenocarcinoma patients. Hum Immunol 75(1):29-33.
42. Jones LL, Vignali DA. 2011. Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily. Immunol Res 51(1): 5-14.
43. Josefowicz SZ, Lu LF, Rudensky AY. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531-564.
44. Kalampokis I, Yoshizaki A, Tedder TF. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 15 (Suppl. 1):S1.
45. Knoechel B, Lohr J, Zhu S, Wong L, Hu D, Ausubel L, Abbas AK. 2006. Functional and molecular comparison of anergic and regulatory T lymphocytes. J Immunol 176(11):6473-6483.
46. Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW. 2010. IL-35 stimulation of CD39 + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 184(12):7144-7153.
47. Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, Layland LE, Vidovic N, Hoerauf A, Oldenburg J, Sauerbruch T, Spengler U. 2010. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci (Lond) 119(2):97-109.
48. Larousserie F, Bardel E, Pflanz S, Arnulf B, Lome-Maldonado C, Hermine O, Bregeaud L, Perennec M, Brousse N, Kastelein R, Devergne O. 2005. Analysis of interleukin-27 (EBI3/ p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am J Pathol 166(4):1217-1228.
49. Li MO, Flavell RA. 2008. TGF-beta: a master of all T cell trades. Cell 134(3):392-404.
50. Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, Gutchigian S, Frisch A, Hodge I, Jiang X, Wang H, Yang XF. 2012. IL-35 is a novel responsive anti-inflammatory cytokine-a new system of categorizing anti-inflammatory cytokines. PLoS One 7(3):e33628.
51. Li Y, Wang Y, Liu Y, Wang Y, Zuo X, Li Y, Lu X. 2014. The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease. Mediators Inflamm 2014:136329.
52. Lin Y, Huang Y, Lu Z, Luo C, shi Y, Zeng Q, Cao Y, Liu L, Wang X, Ji Q. 2012. Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases. PLoS One 7(12):e52490.
53. Liu JQ, Liu Z, Zhang X, Shi Y, Talebian F, Carl JW, Jr., Yu C, Shi FD, Whitacre CC, Trgovcich J, Bai XF. 2012. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 188(7):3099-3106.
54. Liu Y, Wu Y, Wang Y, Cai Y, Hu B, Bao G, Fang H, Zhao L, Ma S, Cheng Q, Song Y, Liu Y, Zhu Z, Chang H, Yu X, Sun A, Zhang Y, Vignali DA, Wu D, Liu H. 2014. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects. Leukemia [Epub ahead of print]; DOI: 10.1038/leu.2014.310.
55. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC. 2002. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169(5):2756-2761.
56. Long J, Zhang X, Wen M, Kong Q, Lv Z, An Y, Wei XQ. 2013. IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun 430(1):364-369.
57. Ma X, Trinchieri G. 2001. Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol 79:55-92.
58. Ma Y, Liu X, Wei Z, Wang X, Xu D, Dai S, Li Y, Gao M, Ji C, Guo C, Zhang L, Wang X. 2014. The expression of a novel anti-inflammatory cytokine IL-35 and its possible significance in childhood asthma. Immunol Lett 162(1 Pt A):11-17.
59. Mahmud SA, Manlove LS, Farrar MA. 2013. Interleukin-2 and STAT5 in regulatory T cell development and function. JAKSTAT 2(1):e23154.
60. Mao H, Gao W, Ma C, Sun J, Liu J, Shao Q, Song B, Qu X. 2013. Human placental trophoblasts express the immunosuppressive cytokine IL-35. Hum Immunol 74(7):872-877.
61. Mauri C, Bosma A. 2012. Immune regulatory function of B cells. Annu Rev Immunol 30:221-241.
62. Mauri C, Ehrenstein MR. 2008. The short history of regulatory B cells. Trends Immunol 29(1):34-40.
63. Mauri C, Nistala K. 2014. Interleukin-35 takes the B line. Nat Med 20(6):580-581.
64. Moore KW, de Waal Malefyt R, Coffman RL, OGarra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
65. Neves P, Lampropoulou V, Calderon-Gomez E, Roch T, Stervbo U, Shen P, Kuhl AA, Loddenkemper C, Haury M, Nedospasov SA, Kaufmann SH, Steinhoff U, Calado DP, Fillatreau S. 2010. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33(5):777-790.
66. Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021-3029.
67. Niedobitek G, Pazolt D, Teichmann M, Devergne O. 2002. Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol 198(3):310-316.
68. Nishino R, Takano A, Oshita H, Ishikawa N, Akiyama H, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y. 2011. Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res 17(19):6272-6286.
69. OShea JJ, Paul WE. 2002. Regulation of T(H)1 differentiation- controlling the controllers. Nat Immunol 3(6):506-508.
70. Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG. 2012. Human prostate tumor antigen- specific CD8 + regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol 189(12):5590-5601.
71. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5):715-725.
72. Ozkan ZS, Deveci D, Simsek M, Ilhan F, Risvanli A, Sapmaz E. 2015. What is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss? J Matern Fetal Neonatal Med 28(3):324-328.
73. Ozkan ZS, Simsek M, Ilhan F, Deveci D, Godekmerdan A, Sapmaz E. 2014. Plasma IL-17, IL-35, interferon-gamma, SOCS3 and TGF-beta levels in pregnant women with preeclampsia, and their relation with severity of disease. J Matern Fetal Neonatal Med 27(15):1513-1517.
74. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, Phillips JH, McClanahan TK, de Waal Malefyt R, Kastelein RA. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172(4): 2225-2231.
75. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal Malefyt R, Rennick D, Kastelein RA. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 + T cells. Immunity 16(6):779-790.
76. Pillai MR, Collison LW, Wang X, Finkelstein D, Rehg JE, Boyd K, Szymczak-Workman AL, Doggett T, Griffith TS, Ferguson TA, Vignali DA. 2011. The plasticity of regulatory T cell function. J Immunol 187(10):4987-4997.
77. Pot C, Jin H, Awasthi A, Liu SM, Lai CY, Madan R, Sharpe AH, Karp CL, Miaw SC, Ho IC, Kuchroo VK. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 183(2):797-801.
78. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U. 1996. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A 93(24):14002-14007.
79. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H. 1993. Infectious transplantation tolerance. Science 259(5097):974-977.
80. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. 2001. Type 1 T regulatory cells. Immunol Rev 182:68-79.
81. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212:28-50.
82. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J. 2010. Biology of interleukin-10. Cytokine Growth Factor Rev 21(5):331-344.
83. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. 2010. FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol 10(7):490-500.
84. Saraiva M, OGarra A. 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol 10(3):170-181.
85. Sauer KA, Maxeiner JH, Karwot R, Scholtes P, Lehr HA, Birkenbach M, Blumberg RS, Finotto S. 2008. Immunosurveillance of lung melanoma metastasis in EBI-3-deficient mice mediated by CD8 + T cells. J Immunol 181(9):6148-6157.
86. Seyerl M, Kirchberger S, Majdic O, Seipelt J, Jindra C, Schrauf C, Stockl J. 2010. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol 40(2):321-329.
87. Shen P, Roch T, Lampropoulou V, OConnor RA, Stervbo U, Hilgenberg E, Ries S, Dang VD, Jaimes Y, Daridon C, Li R, Jouneau L, Boudinot P, Wilantri S, Sakwa I, Miyazaki Y, Leech MD, McPherson RC, Wirtz S, Neurath M, Hoehlig K, Meinl E, Grutzkau A, Grun JR, Horn K, Kuhl AA, Dorner T, Bar-Or A, Kaufmann SH, Anderton SM, Fillatreau S. 2014. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507(7492): 366-370.
88. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al. 1992. Targeted disruption of the mouse transforming growth factorbeta 1 gene results in multifocal inflammatory disease. Nature 359(6397):693-699.
89. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, OShea JJ, Hunter CA. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8(12):1363-1371.
90. Su Y, Zhang AH, Noben-Trauth N, Scott DW. 2011. B-cell gene therapy for tolerance induction: host but not donor B-cell derived IL-10 is necessary for tolerance. Front Microbiol 2:154.
91. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204(8):1775-1785.
92. Tedder TF, Leonard WJ. 2014. Autoimmunity: regulatory B cells-IL-35 and IL-21 regulate the regulators. Nat Rev Rheumatol 10(8):452-453.
93. Tirotta E, Duncker P, Oak J, Klaus S, Tsukamoto MR, Gov L, Lane TE. 2013. Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis. J Neuroimmunol 254(1-2):110-116.
94. Tran DQ. 2012. TGF-beta: the sword, the wand, and the shield of FOXP3( + ) regulatory T cells. J Mol Cell Biol 4(1):29-37.
95. Vignali DA, Kuchroo VK. 2012. IL-12 family cytokines: immunological playmakers. Nat Immunol 13(8):722-728.
96. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA. 2006. IL-27 limits IL-2 production during Th1 differentiation. J Immunol 176(1):237-247.
97. Wan J, Luo Y, Yang C, Liu J, Du Y, Wang K. 2014. [Expression of IL-35, Epstein-Barr virus-induced gene 3 mRNA and IL-12A mRNA in peripheral blood of patients with allergic rhinitis]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 28(13):952-954.
98. Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH, Egwuagu CE. 2014. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 20(6):633-641.
99. Wang Z, Liu JQ, Liu Z, Shen R, Zhang G, Xu J, Basu S, Feng Y, Bai XF. 2013. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol 190(5):2415-2423.
100. Wilson MS, Taylor MD, OGorman MT, Balic A, Barr TA, Filbey K, Anderton SM, Maizels RM. 2010. Helminthinduced CD19 + CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol 40(6): 1682-1696.
101. Wirtz S, Billmeier U, McHedlidze T, Blumberg RS, Neurath MF. 2011. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141(5):1875-1886.
102. Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller- Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C. 2005. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11(23):8326-8331.
103. Wu H, Li P, Shao N, Ma J, Ji M, Sun X, Ma D, Ji C. 2012. Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-beta in acute myeloid leukemia. Oncol Lett 3(5):1119-1123.
104. Xu L, Kitani A, Strober W. 2010. Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal Immunol 3(3):230-238.
105. Yadav M, Stephan S, Bluestone JA. 2013. Peripherally induced tregs - role in immune homeostasis and autoimmunity. Front Immunol 4:232.
106. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. 2008. A regulatory B cell subset with a unique CD1dhiCD5 + phenotype controls T cell-dependent inflammatory responses. Immunity 28(5):639-650.
107. Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, Li X, Sellati R, Jiang H, Zhang S, Li H, Zhao J, Ting AT, Mayer L, Unkeless JC, Labadia ME, Hodge M, Li J, Xiong H. 2008. Epstein- Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 38(5):1204-1214.
108. Yang Y, Xuan M, Zhang X, Zhang D, Fu R, Zhou F, Ma L, Li H, Xue F, Zhang L, Yang R. 2014. Decreased IL-35 levels in patients with immune thrombocytopenia. Hum Immunol 75(8):909-913.
109. Yoshimoto T, Yoshimoto T. 2013. Cytokine Frontiers: Regulation of Immune Responses in Health and Disease. Tokyo, Japan: Springer Japan.
110. Zeng JC, Zhang Z, Li TY, Liang YF, Wang HM, Bao JJ, Zhang JA, Wang WD, Xiang WY, Kong B, Wang ZY, Wu BH, Chen XD, He L, Zhang S, Wang CY, Xu JF. 2013. Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol 6(9):1806-1816.
111. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445(7130): 936-940.